skip to main
|
skip to sidebar
THE AMPYRA CHANNEL
NEWS & TIPS!
Tuesday
Acorda Therapeutics Announces Data On AMPYRA™ (dalfampridine) Presented At American Academy Of Neurology Meeting
Newer Post
Older Post
Home
Blog Archive
►
2016
(8)
►
May
(1)
►
March
(2)
►
February
(5)
►
2015
(16)
►
July
(1)
►
June
(3)
►
March
(1)
►
February
(1)
►
January
(10)
▼
2014
(42)
▼
April
(41)
AMPYRA IMPROVES STANDING BALANCE
"Researchers don’t know why some multiple sclerosi...
Researchers don’t know why some multiple sclerosis...
Biogen Idec to Present New Clinical Data from Its ...
Next Chapter In The Acorda Story Will Be A Page Tu...
Central motor conduction time may predict response...
Study: AMPYRA IMPROVES WALKING FOR MSers
It's no wonder MS is seen as a Cash Cow: THESE MS ...
People Petition For Fampyra to Become a Subsidize...
Jennifer Landry, Columnist, MSnewsChannel.com
Biogen Idec and UCB Enter Agreements to Commercial...
AMPYRA (dalfampridine) 2014 Net Sales Guidance of ...
Tecfidera and Ampyra Show Potential for Quality of...
Tecfidera & Ampyra Show Potential for Quality of L...
STUDY: AMPYRA (Dalfampridine) improves walking spe...
Treatment with dalfampridine (AMPYRA) resulted in ...
VIDEO: Ampyra helps MS patients to walk again
Acorda Therapeutics (Amprya) Recognized by Nationa...
BERLENA HAS PHOTOS & AN AMAZING STORY ABOUT HOW AM...
Extension Data Show Dalfampridine (Amprya) Continu...
The Answers to Frequently Asked Questions About Am...
AAN:Acorda’s Ampyra Runs Ahead of Other Multiple S...
Acorda Therapeutics Announces Data On AMPYRA™ (dal...
Acorda Therapeutics Announces Data on AMPYRA(TM) (...
Research Advocate: Ampyra Approved by FDA to Impro...
New Multiple Sclerosis drug culminates researchers...
Clinical Benefit of Multiple Sclerosis Drug Discov...
"the neuro said he will start me on Ampyra, the wa...
Ampyra is First Symptom Management Drug Developed ...
Acorda Therapeutics Announces Filing of Patent Ext...
Acorda deals MS med direct to patients
An upbeat MS update
MS Learn Online with videos on Ampyra, Med. Mariju...
Ampyra (the new walking pill) - Acorda Therapeutic...
New Multiple Sclerosis Drug
Acorda launches Ampyra ER tablets in US & Puerto Rico
New drug could improve walking ability of people w...
Drug helps MS patients with mobility problems
NMSS Video on Ampyra,New MS "Walking" Drug
MS Drug Ampyra Gets FDA Nod
New Oral MS Drug
►
February
(1)
►
2013
(12)
►
October
(7)
►
September
(2)
►
July
(2)
►
May
(1)
►
2010
(26)
►
May
(1)
►
April
(13)
►
March
(12)
